UniCycive Therapeutics Inc (UNCY)

[Whalatane]

Hi Fred ..sorry I have no idea on OLC qtly rev .
I'm just stunned ARDX was able to sell $25m of XPHOZAH in Q2 despite the fact that 90% of their potential patient population was not covered by Medicare for reimbursement .
Only 10% of the dialysis population are currently reimbursed for Xphozah ...Its around $3,000 a mth with no Medicare coverage / reimbursement

Imagine what sales would be if they were 100% reimbursed by Medicare ...which is what OLC will be once in TDAPA...and FINALLY approved by the FDA .

And OLC lowers serum pho better ...and no major issue with diarrhea .
The ARDX release tells me patients and MD's are desperate for an alternative to the available current pho binders .

JMO
Kiwi